Berlin, Germany

Hans Henning Von Horsten



 

Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2014-2017

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Hans Henning Von Horsten: Innovator in Glycobiology

Introduction

Hans Henning Von Horsten is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of glycobiology, particularly in the development of methods for producing specialized glycan structures. With a total of 2 patents, his work has implications for pharmaceuticals and biotechnology.

Latest Patents

His latest patents include "Methods for preparation of fucose-linked site specific conjugates of proteins with toxins, adjuvants, detection labels and pharmacokinetic half life extenders." This invention focuses on eukaryotic cells that produce molecules with atypical fucose analogs on their glycomeities and/or amino acids. It also details methods for creating conjugates that combine these molecules with pharmaceutical active compounds. Another significant patent is "Process for producing molecules containing specialized glycan structures." This invention relates to cells that produce molecules lacking fucose or containing atypical sugars, along with methods for their production.

Career Highlights

Throughout his career, Hans has worked with various organizations, including Probiogen AG and Hochschule für Technik und Wirtschaft Berlin. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

He has collaborated with notable colleagues such as Volker Sandig and Christiane Ogorek, further enhancing the impact of his work in the field.

Conclusion

Hans Henning Von Horsten is a distinguished inventor whose work in glycobiology continues to influence the development of innovative therapeutic solutions. His patents reflect a commitment to advancing scientific knowledge and improving healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…